Semanteon Capital Management, LP Travere Therapeutics, Inc. Transaction History

Semanteon Capital Management, LP

  • $79.7 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$17.07 - $23.75 $1.19 Million - $1.66 Million
-69,777 Reduced 82.3%
15,006 $269 Million
Q4 2024

Feb 11, 2025
BUY
$13.65 - $19.85 $656,346 - $954,467
48,084 Added 131.02%
84,783 $1.48 Billion
Q3 2024

Oct 24, 2024
BUY
$7.89 - $15.21 $289,555 - $558,191
36,699 New
36,699 $513 Million

Others Institutions Holding TVTX

# of Institutions
269
Shares Held
100M
Call Options Held
2.36M
Put Options Held
955K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $2.21B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Semanteon Capital Management, LP Portfolio

Follow Semanteon Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semanteon Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Semanteon Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email